
Gary W. Counts
Examiner (ID: 6122, Phone: (571)272-0817 , Office: P/1678 )
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1678, 1641, 1677 |
| Total Applications | 1270 |
| Issued Applications | 600 |
| Pending Applications | 185 |
| Abandoned Applications | 497 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9895469
[patent_doc_number] => 20150050668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'ASSAY FOR ANTI-TR ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 14/382007
[patent_app_country] => US
[patent_app_date] => 2012-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7473
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382007
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/382007 | Assay for anti-TR antibodies | Feb 29, 2012 | Issued |
Array
(
[id] => 10568467
[patent_doc_number] => 09291629
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-22
[patent_title] => 'Adiponectin receptor C-terminal fragments (CTF)-immunoglobulin'
[patent_app_type] => utility
[patent_app_number] => 14/111506
[patent_app_country] => US
[patent_app_date] => 2012-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 42326
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111506
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/111506 | Adiponectin receptor C-terminal fragments (CTF)-immunoglobulin | Feb 21, 2012 | Issued |
Array
(
[id] => 8393633
[patent_doc_number] => 20120231475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-13
[patent_title] => 'IMMUNOASSAY FOR DETERMINING THE RELEASE OF NEUROTENSIN INTO THE CIRCULATION'
[patent_app_type] => utility
[patent_app_number] => 13/402551
[patent_app_country] => US
[patent_app_date] => 2012-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5020
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13402551
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/402551 | IMMUNOASSAY FOR DETERMINING THE RELEASE OF NEUROTENSIN INTO THE CIRCULATION | Feb 21, 2012 | Abandoned |
Array
(
[id] => 8240857
[patent_doc_number] => 20120149596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'METHODS FOR ASSESSING ATHEROGENESIS BY DETERMINING OXIDIZED PHOSPHOLIPID TO APOLIPOPROTEIN B RATIOS'
[patent_app_type] => utility
[patent_app_number] => 13/400392
[patent_app_country] => US
[patent_app_date] => 2012-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15780
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13400392
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/400392 | METHODS FOR ASSESSING ATHEROGENESIS BY DETERMINING OXIDIZED PHOSPHOLIPID TO APOLIPOPROTEIN B RATIOS | Feb 19, 2012 | Abandoned |
Array
(
[id] => 8453202
[patent_doc_number] => 20120264149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'METHOD FOR THE DETERMINATION OF THE FORMATION OF ENDOTHELINS FOR MEDICAL DIAGNOSTIC PURPOSES, AND ANTIBODIES AND KITS FOR CARRYING OUT SUCH A METHOD'
[patent_app_type] => utility
[patent_app_number] => 13/398211
[patent_app_country] => US
[patent_app_date] => 2012-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6016
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13398211
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/398211 | Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method | Feb 15, 2012 | Issued |
Array
(
[id] => 8335592
[patent_doc_number] => 20120202297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'GENDER DETERMINATION METHOD'
[patent_app_type] => utility
[patent_app_number] => 13/367944
[patent_app_country] => US
[patent_app_date] => 2012-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7100
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13367944
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/367944 | GENDER DETERMINATION METHOD | Feb 6, 2012 | Abandoned |
Array
(
[id] => 11390484
[patent_doc_number] => 09551723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'Liquid reagent of thyroid hormone-immobilized carrier and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/365099
[patent_app_country] => US
[patent_app_date] => 2012-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9032
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13365099
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/365099 | Liquid reagent of thyroid hormone-immobilized carrier and use thereof | Feb 1, 2012 | Issued |
Array
(
[id] => 9537650
[patent_doc_number] => 20140162297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 13/983374
[patent_app_country] => US
[patent_app_date] => 2012-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16319
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983374
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/983374 | Anti-carbamylated protein antibodies and the risk for arthritis | Jan 31, 2012 | Issued |
Array
(
[id] => 9295207
[patent_doc_number] => 20140038841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'BIOMARKERS FOR OSTEOARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 13/982696
[patent_app_country] => US
[patent_app_date] => 2012-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9009
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982696
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/982696 | BIOMARKERS FOR OSTEOARTHRITIS | Jan 30, 2012 | Abandoned |
Array
(
[id] => 16909831
[patent_doc_number] => 11041864
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Method for prediction of prognosis of sepsis
[patent_app_type] => utility
[patent_app_number] => 13/979133
[patent_app_country] => US
[patent_app_date] => 2012-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5819
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979133
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/979133 | Method for prediction of prognosis of sepsis | Jan 9, 2012 | Issued |
Array
(
[id] => 8554945
[patent_doc_number] => 08329417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Non-proteolytic method for the determination of analytes in keratinized structures'
[patent_app_type] => utility
[patent_app_number] => 13/336119
[patent_app_country] => US
[patent_app_date] => 2011-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5959
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13336119
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/336119 | Non-proteolytic method for the determination of analytes in keratinized structures | Dec 22, 2011 | Issued |
Array
(
[id] => 8453284
[patent_doc_number] => 20120264230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => ' HOME OR POINT-OF-CARE ALLERGY TESTING'
[patent_app_type] => utility
[patent_app_number] => 13/335808
[patent_app_country] => US
[patent_app_date] => 2011-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8529
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13335808
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/335808 | HOME OR POINT-OF-CARE ALLERGY TESTING | Dec 21, 2011 | Abandoned |
Array
(
[id] => 10863676
[patent_doc_number] => 08889370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-18
[patent_title] => 'Method of determining inhibitors of coagulation'
[patent_app_type] => utility
[patent_app_number] => 13/332441
[patent_app_country] => US
[patent_app_date] => 2011-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 11053
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13332441
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/332441 | Method of determining inhibitors of coagulation | Dec 20, 2011 | Issued |
Array
(
[id] => 8591745
[patent_doc_number] => 08349620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-08
[patent_title] => 'Highly sensitive immunoassay systems for detecting multiple allergens'
[patent_app_type] => utility
[patent_app_number] => 13/312977
[patent_app_country] => US
[patent_app_date] => 2011-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 2
[patent_no_of_words] => 8553
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 350
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13312977
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/312977 | Highly sensitive immunoassay systems for detecting multiple allergens | Dec 5, 2011 | Issued |
Array
(
[id] => 8853564
[patent_doc_number] => 20130143239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'Melittin Peptide Conjugates And Methods Employing Same'
[patent_app_type] => utility
[patent_app_number] => 13/308918
[patent_app_country] => US
[patent_app_date] => 2011-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9200
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13308918
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/308918 | Melittin Peptide Conjugates And Methods Employing Same | Nov 30, 2011 | Abandoned |
Array
(
[id] => 8502498
[patent_doc_number] => 20120301906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'TSH IMMUNOASSAYS EMPLOYING SCAVENGING REAGENTS FOR CROSS-REACTING ENDOCRINE GLYCOPROTEIN HORMONE ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 13/306712
[patent_app_country] => US
[patent_app_date] => 2011-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15627
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306712
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/306712 | TSH immunoassays employing scavenging reagents for cross-reacting endocrine glycoprotein hormone analogues | Nov 28, 2011 | Issued |
Array
(
[id] => 9068725
[patent_doc_number] => 20130260481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'ANALYSIS DEVICE AND ANALYSIS METHOD'
[patent_app_type] => utility
[patent_app_number] => 13/993282
[patent_app_country] => US
[patent_app_date] => 2011-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19001
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993282
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993282 | ANALYSIS DEVICE AND ANALYSIS METHOD | Nov 17, 2011 | Abandoned |
Array
(
[id] => 10905663
[patent_doc_number] => 20140308676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/885146
[patent_app_country] => US
[patent_app_date] => 2011-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7773
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885146
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/885146 | CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE | Nov 13, 2011 | Abandoned |
Array
(
[id] => 9134865
[patent_doc_number] => 20130295580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'ORAL CANCER POINT OF CARE DIAGNOSTICS'
[patent_app_type] => utility
[patent_app_number] => 13/884702
[patent_app_country] => US
[patent_app_date] => 2011-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6201
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884702
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/884702 | Oral cancer point of care diagnostics | Nov 10, 2011 | Issued |
Array
(
[id] => 8185253
[patent_doc_number] => 20120115175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'METHODS FOR DIAGNOSING ELEVATED RIGHT OR LEFT VENTRICULAR FILLING PRESSURE'
[patent_app_type] => utility
[patent_app_number] => 13/288493
[patent_app_country] => US
[patent_app_date] => 2011-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7183
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115175.pdf
[firstpage_image] =>[orig_patent_app_number] => 13288493
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/288493 | METHODS FOR DIAGNOSING ELEVATED RIGHT OR LEFT VENTRICULAR FILLING PRESSURE | Nov 2, 2011 | Abandoned |